{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:05:21Z","timestamp":1793394321424,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ajo.2020.11.012","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T11:43:51Z","timestamp":1606995831000},"page":"228-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Ten-Year Progression From Intermediate to Exudative Age-Related Macular Degeneration and Risk Factors: Bundang AMD Cohort Study Report 1"],"prefix":"10.1016","volume":"224","author":[{"given":"Kwangsic","family":"Joo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Seok","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0542-2758","authenticated-orcid":false,"given":"Sang Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5516-8121","authenticated-orcid":false,"given":"Kyu Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Joon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2020.11.012_bib1","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ophtha.2014.03.013","article-title":"Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene\/environment susceptibility study","volume":"121","author":"Jonasson","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2020.11.012_bib2","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.ophtha.2012.11.041","article-title":"Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study","volume":"120","author":"Klein","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib3","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.ajo.2020.11.012_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archopht.116.5.653","article-title":"Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study","volume":"116","author":"Klaver","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2020.11.012_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1755-3768.2008.01191.x","article-title":"Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study","volume":"86","author":"Gunnlaugsdottir","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1442-9071.2000.00315.x","article-title":"Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study","volume":"28","author":"Wang","year":"2000","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2020.11.012_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ophtha.2009.10.007","article-title":"The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis","volume":"117","author":"Kawasaki","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2020.11.012_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/APO.0b013e31827ff5bc","article-title":"Asian age-related macular degeneration: current concepts and gaps in knowledge","volume":"2","author":"Lim","year":"2013","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"8","key":"10.1016\/j.ajo.2020.11.012_bib10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ophtha.2014.02.004","article-title":"Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays","volume":"121","author":"Cheung","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajo.2011.02.004","article-title":"Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network","volume":"152","author":"Vanderbeek","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.11.012_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","article-title":"Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis","volume":"113","author":"Klein","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2020.11.012_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2015.12.026","article-title":"Incidence of age-related macular degeneration in a multi-ethnic United States population: the multi-ethnic study of atherosclerosis","volume":"123","author":"Fisher","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archophthalmol.2011.376","article-title":"Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort","volume":"130","author":"Cheung","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.11.012_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","article-title":"The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1","volume":"20","year":"1999","journal-title":"Control Clin Trials"},{"issue":"12","key":"10.1016\/j.ajo.2020.11.012_bib16","first-page":"2224","article-title":"Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3","volume":"107","year":"2000","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.11.012_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2020.11.012_bib18","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A simplified severity scale for age-related macular degeneration: AREDS report no. 18","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.11.012_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamaophthalmol.2013.6636","article-title":"Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(95)31034-2","article-title":"The prevalence of age-related maculopathy in the Rotterdam study","volume":"102","author":"Vingerling","year":"1995","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2006.10.040","article-title":"Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study","volume":"114","author":"Klein","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2020.11.012_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ophtha.2006.07.017","article-title":"Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study","volume":"114","author":"Wang","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.11.012_bib51","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/ncomms7063","article-title":"New loci and coding variant confer risk for age-related macular degeneration in East Asians.","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajo.2020.11.012_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","article-title":"Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19","volume":"112","author":"Clemons","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1020514804325","article-title":"Correction of the p-value after multiple tests in a Cox proportional hazard model","volume":"8","author":"Hashemi","year":"2002","journal-title":"Lifetime Data Anal"},{"issue":"6","key":"10.1016\/j.ajo.2020.11.012_bib27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0161-6420(03)00599-2","article-title":"The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study","volume":"110","author":"Klein","year":"2003","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2020.11.012_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","article-title":"Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis","volume":"160","author":"Rudnicka","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2020.11.012_bib29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bjophthalmol-2011-301109","article-title":"The estimated prevalence and incidence of late stage age related macular degeneration in the UK","volume":"96","author":"Owen","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2020.11.012_bib30","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.ophtha.2009.04.017","article-title":"Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study","volume":"116","author":"Yasuda","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2020.11.012_bib31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ophtha.2017.03.056","article-title":"Six-year incidence of age-related macular degeneration in Asian Malays: the Singapore Malay Eye Study","volume":"124","author":"Cheung","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1167\/iovs.13-13096","article-title":"Prevalence and risk factors of age-related macular degeneration in Korea: the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"55","author":"Cho","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2020.11.012_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bjophthalmol-2011-300193","article-title":"Age-related macular degeneration: the importance of family history as a risk factor","volume":"96","author":"Shahid","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2020.11.012_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archopht.124.7.995","article-title":"Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration","volume":"124","author":"Seddon","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a116659","article-title":"The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking","volume":"137","author":"Klein","year":"1993","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.ajo.2020.11.012_bib36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.1996.01100140716016","article-title":"Smoking and age-related maculopathy. The Blue Mountains Eye Study","volume":"114","author":"Smith","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"14","key":"10.1016\/j.ajo.2020.11.012_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.1996.03540140029022","article-title":"A prospective study of cigarette smoking and age-related macular degeneration in women","volume":"276","author":"Seddon","year":"1996","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ajo.2020.11.012_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.ophtha.2014.04.040","article-title":"Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study","volume":"121","author":"Myers","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2020.11.012_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1753-4887.2008.00078.x","article-title":"Phytochemicals and age-related eye diseases","volume":"66","author":"Rhone","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ajo.2020.11.012_bib40","first-page":"2528","article-title":"Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in ARPE19 cells","volume":"14","author":"Chan","year":"2008","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.ajo.2020.11.012_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.09.067","article-title":"Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate","volume":"1124","author":"Zhang","year":"2006","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.ajo.2020.11.012_bib42","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1167\/iovs.09-4000","article-title":"Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms","volume":"51","author":"Edwards","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2020.11.012_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial","volume":"273","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ajo.2020.11.012_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","article-title":"Postmenopausal estrogen and progestin use and the risk of cardiovascular disease","volume":"335","author":"Grodstein","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajo.2020.11.012_bib45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/IAE.0b013e3181a3b90e","article-title":"Analyses of single nucleotide polymorphisms and haplotype linkage of LOC387715 and the HTRA1 gene in exudative age-related macular degeneration in a Chinese cohort","volume":"29","author":"Jiang","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.11.012_bib46","first-page":"1395","article-title":"Joint effects of polymorphisms in the HTRA1, LOC387715\/ARMS2, and CFH genes on AMD in a white population","volume":"14","author":"Francis","year":"2008","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.ajo.2020.11.012_bib47","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1167\/iovs.07-0860","article-title":"Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy","volume":"49","author":"Lee","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2020.11.012_bib48","doi-asserted-by":"crossref","first-page":"e0132771","DOI":"10.1371\/journal.pone.0132771","article-title":"Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration","volume":"10","author":"Woo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2020.11.012_bib49","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s10792-017-0666-4","article-title":"Spectrum of pachychoroid diseases","volume":"38","author":"Akkaya","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.11.012_bib50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10384-007-0503-9","article-title":"Polypoidal choroidal vasculopathy with drusen","volume":"52","author":"Iwama","year":"2008","journal-title":"Jpn J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420306462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420306462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:45:38Z","timestamp":1757598338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420306462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":51,"alternative-id":["S0002939420306462"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.11.012","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-Year Progression From Intermediate to Exudative Age-Related Macular Degeneration and Risk Factors: Bundang AMD Cohort Study Report 1","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}